Fordham, N; Baker, E; Forton, D; Klammer, M; Patel, K; Qadir, D; Reyal, Y; Willis, F; Koh, MBC
(2021)
First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID-19 in an allogeneic stem cell transplant patient.
EJHaem, 2 (1).
pp. 143-146.
ISSN 2688-6146
https://doi.org/10.1002/jha2.132
SGUL Authors: Baker, Emma Harriet
|
PDF
Published Version
Download (441kB) | Preview |
Official URL: https://doi.org/10.1002/jha2.132
| Item Type: | Article |
|---|---|
| Additional Information: | © 2020 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| SGUL Research Institute / Research Centre: | Academic Structure > Infection and Immunity Research Institute (INII) |
| Journal or Publication Title: | EJHaem |
| ISSN: | 2688-6146 |
| Language: | eng |
| PubMed ID: | 35846103 |
 |
Go to PubMed abstract |
| URI: | https://openaccess.sgul.ac.uk/id/eprint/114541 |
| Publisher's version: | https://doi.org/10.1002/jha2.132 |
Statistics
Item downloaded times since 21 Jul 2022.
Actions (login required)
 |
Edit Item |